IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Ticker index
AGIO
Ticker

AGIO

Congressional Trades
13
by 2 members
Ticker disclosure brief

Congressional disclosure records for AGIO

A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.

Latest receipt
Gilbert Cisneros
BUY · 2026-03-03
Largest range
$1K – $15K
Gilbert Cisneros
Longest observed gap
36d
Gilbert Cisneros
Highest 30d vs SPY
39.0%
Gilbert Cisneros
Purchase rows
13
100%
Sale rows
0
0%
Disclosed midpoint
$104K
range estimate
Unique Traders
2
members
Disclosure timing method

Observed filing gaps are not notice-date findings

The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.

Party Breakdown

Democrats13 · 100%
Republicans0 · 0%

Lobbying filings

all →
  • 2026-05-26$0
    AGIOS PHARMACEUTICALS
    Issues related to patient access to innovative therapies
  • 2026-04-20$10K
    AGIOS PHARMACEUTICALS INC.
    Issues related to prescription drugs
  • 2026-04-17$70K
    AGIOS PHARMACEUTICALS
    Sickle Cell Policy Biotech Innovation Biotech Innovation Medicaid Reform
  • 2026-01-20$20K
    AGIOS PHARMACEUTICALS
    Sickle Cell policy Biotech innovation Biotech Innovation Medicaid Reform
  • 2026-01-20$10K
    AGIOS PHARMACEUTICALS INC.
    Issues related to prescription drugs
  • 2026-01-09$0
    AGIOS PHARMACEUTICALS INC.
    issues related to prescription drugs
  • 2025-10-17$10K
    AGIOS PHARMACEUTICALS
    Sickle Cell policy Biotech innovation Biotech Innovation Medicaid Reform
  • 2025-07-22$20K
    AGIOS PHARMACEUTICALS
    Sickle Cell policy Biotech innovation Medicaid reform Biotech innovation
  • 2025-06-12$0
    AGIOS PHARMACEUTICALS
    Pharmacy, Medicare/Medicaid, Health Issues Pharmacy, Medicare/Medicaid, Health Issues Pharmacy, Medicare/Medicaid, Health Issues
Loading trade analytics…

All Disclosed Trades

Page 1 · 13 of 13 shown
DateMemberActionAmountObserved GapReceipt
2026-03-03DGilbert CisnerosBUY$1K – $15K36dreceipt →
2026-03-03DGilbert CisnerosBUY$1K – $15K36dreceipt →
2026-03-03DGilbert CisnerosBUY$1K – $15K35dreceipt →
2026-03-03DGilbert CisnerosBUY$1K – $15K35dreceipt →
2025-12-11DGilbert CisnerosBUY$1K – $15K33dreceipt →
2025-12-11DGilbert CisnerosBUY$1K – $15K32dreceipt →
2025-12-11DGilbert CisnerosBUY$1K – $15K32dreceipt →
2025-04-17DGilbert CisnerosBUY$1K – $15K19dreceipt →
2025-04-17DGilbert CisnerosBUY$1K – $15K19dreceipt →
2025-01-29DGilbert CisnerosBUY$1K – $15K13dreceipt →
2025-01-29DGilbert CisnerosBUY$1K – $15K13dreceipt →
2024-01-24DJosh GottheimerBUY$1K – $15K22dreceipt →
2024-01-24DJosh GottheimerBUY$1K – $15K22dreceipt →

“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.